MEAGAN CHAVARRIA: Open Payments
NPI 1467843086 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,407 in 128 payments from 20 companies in 2025. Trend: 2023 $1,556 · 2024 $6,523 · 2025 $12,407
Speaker / faculty: $4,410Travel & lodging: $4,223Food & beverage: $2,100Consulting: $1,674
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 20 | $7,876 |
| Actelion Pharmaceuticals US, Inc. | 21 | $2,286 |
| United Therapeutics Corporation | 25 | $902 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $259 |
| Baxter Healthcare | 16 | $233 |
| Grifols USA, LLC | 8 | $196 |
| Insmed, Inc. | 5 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $89 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Astellas Pharma US Inc | 2 | $59 |
Products named: WINREVAIR, UPTRAVI, Tyvaso, Adempas, Hillrom - Vest System Model 105 Home Care, Prolastin-C Liquid, OPSUMIT, Arikayce.
Industry payments across TX — which companies pay providers there.
